Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion;Bevacizumab zur Therapie des Makulaödems Infolge Venöser Retinaler Gefäßverschlüsse

Ophthalmologe

Volumn 104, Issue 4, 2007, Pages 285-289

  Schaal, K B ^a   Hoh A E ^a   Scheuerle, A ^a   Schutt F ^a   Dithmar, S ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Bevacizumab; Branch retinal vein occlusion; Central retinal vein occlusion; Macular edema; VEGF

Indexed keywords

EID: 34247469751     PISSN: 0941293X     EISSN: 14330423     Source Type: Journal    
DOI: 10.1007/s00347-007-1509-x     Document Type: Article

References (9)

1. Geitzenauer W, Michels S, Prager F et al. (2006) Frühe Effekte nach systemischer und intravitrealer Bevacizumab (Avastin® ) Therapie bei neovaskulärer altersbedingter Makuladegeneration. Klin Monatsbl Augenheilkd 223: 822-827
2. Iturralde D, Spaide RF, Meyerle CB et al (2006) Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion. A short term study. Retina 26: 279-284
3. Jaissle GB, Ziemssen F, Petermeier K et al (2006) Bevacizumab zur Therapie des sekundären Makulaödems nach venösen Gefäßverschlüssen. Ophthalmologe 103: 471-475
4. Luthra S, Narayanan R, Marques LEA et al. (2006) Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal and microvascular endothelial cells. Retina 26: 512-518
5. Manzano RP, Peyrnan GA, Khan P et al. (2006) Testing intravitreal toxicity of bevacizumab (Avastin). Retina 26: 257-261
6. Noma H, Funatsu H, Yamasaki M et al. (2005) Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 140: 256-261
7. Noma H, Minamoto A, Funatsu H et al. (2006) Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 244: 309-315
8. Pe'er J, Folberg R, Itin A et al. (1998) Vascular endothelial growth factor upregulation in human central vein occlusion. Ophthalmology 105: 412-416
9. Rosenfeld PJ, Fung AE, Puliafito CA (2005) Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 36: 336-339